The OSR, Office of Clinical Trial Activation (OCTA), and Contracts and Grants Accounting (CGA) are working to ensure continuity of services for researchers, as well as prioritizing COVID-19 research and clinical trials.
Go to our COVID-19 page for sponsor specific guidance, the impact of research and additional resources.
Below are funding opportunities related to COVID-19 seperated by Sponsor.
Please notify your RSC of any intention to submit a proposal ASAP.
- ADA
- AHA
- AHRQ
- BARDA
- C3.ai
- CDC
- CIRM
- Emergent Ventures
- Harrington Discovery Institute
- Henry Wheeler Center for Emerging & Neglected Disease (CEND)
- National Autonomous University of Mexico (UNAM) and University of California (UC) through Alianza UCMX)
- NIH
- NSF
- PCORI
- UC - RGPO
- UCSF
- US Army Medical Research & Development Command's CDMRP
- White House
ADA - American Diabetes Association
American Diabetes Association COVID-19 and Diabetes Research Call for Application (see RFA). Due May 22nd.
AHA - American Heart Association
- AHA Rapid Response Grant COVID-19 and Its Cardiovascular Impact. Due Date April 6th.
AHRQ - Agency for Healthcare research and Quality
- PA-20-070 Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) Due: May 29, 2020, 5 PM local time
- PA-20-072 Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Helth System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) Due: May 29, 2020, 5 PM local time
BARDA - Biomedical Advanced Research and Development Authority
C3.ai Digital Transformation Instititue
- Mitigation of COVID-19 and Future Pandemics
- Deadline May 1, 2020
- Co-Investigators can be from any institution, but Principal Investigators must be researchers from C3.ai DTI consortium member institutions, including the University of California, Berkeley (UC Berkeley), C3.ai, Microsoft, the University of Illinois at Urbana-Champaign (UIUC), Carnegie Mellon University, University of Chicago, MIT, and Princeton University.
CDC - Center for Disease Control
- National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) https://www.cdc.gov/ncezid/index.html
- BAA-75D301-20-R067897: Applied research to Address the Coronavirus (COVID-19) Emerging Public Health Emergency
CIRM - California Institute for Regenerative Medicine
- Announcement - Stem Cell Agency Board Approves $5 Million in Emergency Funding for COVID-19 Research
- Special Call for COVID-19 Projects - CIRM is establishing an open call for proposals and will accept applications on a bi-monthly basis. The first deadline for applications will be on Tuesday, April 7, 2020 at 2pm PST.
Emergent Ventures - Mercatus Center at George Mason University
- Fastgrants.org
- No specific due date, decisions made within 48hours - first award will be made April 12th
- Must be a currently working on a COVID-19 project
Harrington Discovery Institute
- Harrington Scholar Award for Coronavirus
- Due Date April 30, 2020 5:00pm EDT
- Request for Proposal
- Application Questions
Henry Wheeler Center for Emerging & Neglected Diseases (CEND)
- COVID Catalyst - Rapid Funding to accelerate COVID-19 research within Bay Area Virus Network
- Accepting Applications on a rolling, first come first serve basis
National Autonomous University of Mexico (UNAM) and University of California (UC) through Alianza UCMX)
- Special Call for Binational Collaborative Projects Addressing COVID-19
- Funded on Rolling Basis, Final Due Date: May 30, 2020 at 6pm Pacific Time
- First Stage up to $10,000, Second Stage up to $25,000
NIH - National Institutes of Health
Go to the NIH COVID-19 Information for NIH Applicants and Recipients page for a complete list of Funding Opportunities Specific to COVID-19
NCI - NOT-CA-20-065 Request For Information (RFI): Strategy for Research in Coronavirus Serology Testing and Serological Sciences, Response Due: May 26, 2020
NCI - NOT-CA-20-054 Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be redirected to COVID-19-Related Research During the Crisis
NHLBI - Research Opportunity Announcement (ROA) OTA-20-011 ACTIV Integration of Host-targeting Therapies for COVID19 Stage 1 Letters of Request Due: Friday, May 15, 5 PM EDT. Additional letters of request considered on a monthly basis June 15, July 15, and August 15.
NIBIB - NIH POCTRN - Fast-Track Program for COVID-19 Test Development and Distribution Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing Rolling Submission from April 29, 2020 until further ntoice.
Below is a listing of Notices of Special Interest (NOSIs) for:
COVID-19 Applications:
| NIH IC | NOSI | NOSI Expiration | Title | FOAs Used |
| NIAID |
|
|||
| NIH Office of Strategic Coordination |
|
|||
| NIAID | NOT-AI-20-051 | 9/8/21 | Select Research Areas for Severe Acute-Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
|
| OPPNET, NIA, NIAAA, NICHD, NIDA, NIMH, NINDS, NINR, NIMHD, NCCIH, OBSSR | NOT-OD-20-103 | 3/18/21 | Notice of Additional Due Date and Additional "Areas of Focus Especially of Interest" of PAR-19-373 and PAR-19-384 |
|
| NIDCR | Infrastructure Access for Research on Coronavirus disease 2019 (COVID-19) Conducted in the National Dental Practice-based Research Network |
|
||
| NLM | NOT-LM-20-011 | 6/17/20 | Data Driven Research on Coronavirus Disease 2019 (COVID-19) |
|
| NCATS | NOT-TR-20-012 | 10/17/20 | Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) |
|
| NIBIB | 3/31/21 | Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) |
|
|
| NIEHS |
NOT-ES-20-015 Rescinded 4/10/20 replaced by NOT-ES-20-20 |
4/9/20 | NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) |
|
| NIEHS | 5/4/21 | NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) |
|
COVID-19 Supplements for Exisiting Awards:
| NIH IC | COVID NOSI |
Competing PA-20-135 expands scope |
Competing expands scope |
Adminis. within scope |
Noted Requirements (please see NOSI for all requirements specified) | Deadline | Release | Expires |
| NIAID | NOT-AI-20-034 | X | FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25 | Rolling basis from 3/25/20-3/25/21 | 3/25/20 | 3/25/21 | ||
| NIAID |
NOT-AI-20-031 Rescinded 5/19/20 Replaced by NOSI NOT-AI-20-051 R03, R41/R42, R43/R44 or use PAR-177 PAR-178 See Application Grid above |
X |
Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25 |
Rolling basis from 4/5/20-4/5/21 | 3/27/20 |
4/5/21 5/19/20 |
||
| NIBIB | NOT-EB-20-008 | X | X |
Limited to DP1, DP2, P41, R00, R01, R03, R15, R21, R24, R37, R41, R43, R44, R56, U01, U18, U24, U2C, U54, UG3, UH2, UH3 Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25 |
Rolling basis from 4/2/20-11/10/20 | 4/10/20 | 11/10/20 | |
| NIEHS |
NOT-ES-20-014 Rescinded 4/10/20 replaced by NOT-ES-20-017 |
X |
Must have active grant from:
|
4/24/20 | 3/27/20 |
4/25/20 4/10/20 |
||
| NIEHS |
NOT-ES-20-015 Rescinded 4/10/20 replaced by NOT-ES-20-20 |
X |
One year support for supplements. FOA will be reissued with FORMS-F on May 25. FORMS-E will expire June 25 New R21 applications use RFA-ES-19-011 (see table above) up to two years support.
|
5/1/ earliest see NOSI | 4/9/20 |
5/4/21 4/10/20 |
||
| NIEHS | NOT-ES-20-017 | X |
Must have active grant from RFA-ES-14-008, RFA-ES-14-009, RFA-ES-15-018, RFA-ES-17-004, RFA-ES-18-006, RFA-ES-19-009 |
4/24/20 | 4/10/20 | 4/25/20 | ||
| NIEHS | NOT-ES-20-20 | X | X |
FOA will be reissued with FORMS-F on May 25. FORMS-E will expire June 25. New R21 applications use RFA-ES-19-011 (see table above) |
Earliest 5/1/20, see NOSI for furture dates | 4/10/20 | 5/4/21 | |
|
OSC |
NOT-RM-20-015 | X |
Pre-application teleconference to be posted on Common Fund site. Limited to D43, DP2, DP5, DP7, R01, R24, R25, R35, U01, U18, U19, U24, U2C, U2R, U42, U54, UG3, UH2, UH3, UM1 FOA will be reissued with FORMS-F on May 25. FORMS-E and F will expire on June 20. |
Rolling Basis from 4/15/20-6/19/20 | 4/27/20 | 6/20/20 | ||
| NCATS | NOT-TR-20-017 | X |
Only existing UG3/UH3, R43/R44, R41/R42, R01, U01 NCATS/NIH Microphysiological Systems FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25 |
Rolling basis from 5/15/20-1/25/22 | 4/9/20 | 1/26/22 | ||
| NCATS | NOT-TR-20-028 | X | X |
Soliciting current CTSA UL1 & U24 recipients of RFA-TR-17-006 RFA-tr-15-004 PAR-18-940 UL1 component only PAR-18-464 UL1 component only PAR-15-304 UL1 component only RFA-TR-14-009 UL1 Component only Admin. Supp. Cannot use streamline submission in eRA. FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25 |
Rolling basis from 5/4/20-11/11/20 | 4/23/20 | 11/11/20 | |
| NIAAA | NOT-AA-20-011 | X | X |
Admin. Supp. Cannot use streamline submission in eRA. FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25 |
Rolling basis 5/15/20-4/16/21 | 4/16/20 | 4/16/21 | |
| NIA/NIMH | X | X |
Admin. Supp. Cannot use streamline submission in eRA. FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25 |
Rolling basis from 4/6/20-5/1/21 | 4/2/20 | 5/21/21 | ||
|
NCCIH/ORWH |
NOT-AT-20-012 | X | X |
Only existing awardees of NCCIH active awards. Admin. Supp. Cannot use streamline submission in eRA. PA-18-591 and PA-18-935 were reissued with FORMS-F on 5/25/20 Applications started using FORMS-E must be completed by 6/25/20 |
Rolling through 8/17/20 | 5/26/20 | 8/18/20 | |
|
NCCIH/NIA/ NIAAA |
NOT-AT-20-011 | X | X |
Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/25/20 |
Rolling basis from 4/10/20-10/6/20 | 4/10/20 | 10/7/20 | |
| NCI | NOT-CA-20-042 | X | X |
Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/25/20 Contact parent Program Director before writing and submitting applications. |
Rolling basis from 4/14/20-6/25/20 | 4/10/20 | 6/26/20 | |
| NIDA | NOT-DA-20-047 | x | x |
Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/25/20 |
Rolling basis from 3/19/20-3/31//21 | 3/19/20 | 3/31/21 | |
| NIDCD | NOT-DC-20-004 | X | X |
Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/1/20 |
Rolling basis from 4/7/20-6/1/20 | 4/9/20 | 6/2/20 | |
| NIDCR | X | X |
Includes R42, R44, SB1, K01, K08, K23, K25, K99/R00, R01, R15, R37, U01, U19, UH3 Admin. Supplement cannot use streamline submission in eRA Commons Must use application form package with the Competition ID that contains FORMS-F-ADMINSUPP |
6120 and 11/2/20 | 5/5/20 | |||
| NIDDK | NOT-DK-20-018 | X |
FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/1/20 Contact with NIDDK program staff is strongly recommended |
6/1/20 | 4/9/20 | 6/2/20 | ||
| NIDDK | NOT-DK-20-020 | X |
FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/1/20 Contact with NIDDK program staff is strongly recommended |
6/1/20 | 4/9/20 | 6/2/20 | ||
| NIGMS | NOT-GM-20-025 | X |
FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25 |
Rolling basis from 3/25-2/5/21 | 3/25/20 | 2/6/21 | ||
| NIGMS | NOT-GM-20-027 | X | Notify contact on NOSI when application submitted. | 5/5/20 | 4/10/20 | 5/6/20 | ||
| NIGMS | NOT-GM-20-033 | X |
For awardees with an active NIGMS IDeA-CTR U54 Must use application form package with Competition ID NOT-GM-20-033-FORMS-F |
6/18/20 | 5/15/20 | 6/19/20 | ||
| NHGRI | X | X |
Admin. Supp. cannot use streamline submission in eRA Commons. Contact with NHGRI Program staff strongly recommended |
Rolling basis from 4/1-5/15 | 3/31/20 | 5/16/20 | ||
| NHLBI | X |
Phase I-III CT, parent P01, R01, R33, R41, R42, R43, R44, U01, U24, U54, UH3, UM1 OA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25 |
Rolling basis from 5/1/20-10/5/20 | 4/27/20 | 10/6/20 | |||
| NHLBI |
Expires 5/15/20 see NOT-HL-20-782 or OTA-20-011 |
X | X |
Admin. Supp. Cannot use streamline submission in eRA. FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25 Contact with NHLBI progran staff well in advance is strongly recommended. |
Rolling basis from 3/17-05/15/20 | 3/17/20 | 5/15/20 | |
|
NLM |
NOT-LM-20-010 | X |
Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25 |
6/1/20 | 4/16/20 | 6/2/20 | ||
|
NIMHD NIA/NIMH |
NOT-MD-20-019 | X | X |
FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25 |
Rolling basis from 5/1/20-5/1/21 | 4/9/20 | 5/1/21 | |
|
NIMH NIA/NIAAA/ NIMHD/ ODP |
NOT-MH-20-047 | X | X |
May be co-funded by ODP FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25 |
Rolling basis from 3/27/20-4/15/21 | 4/9/20 | 4/16/21 | |
|
NINDS |
NOT-NS-20-046 | X | X |
Active U01 or U24 for FOA RFA-NS-19-024, RFA-NS-17-02, RFA-NS-16-015, RFA-NS-13-016, RFA-NS-11-010 Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25 |
Rolling basis from 4/6/20-5/8/20 | 4/14/20 | 5/9/20 | |
|
NINDS |
NOT-NS-20-074 adds RF1 to eligible mechanisms |
X | X |
Limited to P01, P50, RF1,R00, R01, R03, R15, R33, R35, R41, R42, R43, R44, R61, U01, U19, U24, U44, U54, UG3, UH3 Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25 |
Rolling basis from 4/15/20-4/14/21 | 4/30/20 | 4/15/21 | |
|
OD Office of the Director
|
NOT-OD-20-107 | X |
EsixtingECHO Cohorts, Coordinating Center, Data Analysis Center and PRO Core Awardees Existing Subawardees not eligible Use application form package with Competition ID that contains FORMS-F-ADMINSUPP |
6/22/20 | 5/27/20 | 6/23/20 | ||
|
OBSSR/NHLBI/ NIA/NIAAA/ NIDDK/NIEHS/ NCCIH/NCI |
NOT-OD-20-097 | X | X |
Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25 |
Rolling basis from 4/13/20-3/31/21 | 4/13/20 | 4/1/21 | |
|
NCATS |
NOT-TR-20-011 | X |
Supplements U01-PAR-19-099 R21-PAR-19-100 UL1-PAR-19-337 Admin. Supp. cannot use streamline submission in eRA Commons. FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25 |
5/4/20 AND 11/2/20 | 3/24/20 | 7/10/21 | ||
|
NCATS |
NOT-TR-20-016 | X |
Admin. Supp. cannot use streamline submission in eRA Commons. FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25 |
Rolling basis from 5/15/20-1/25/22 | 4/9/20 | 1/26/22 | ||
|
NIAID |
NOT-AI-20-040 |
Early termination of NOT-AI-20-030 (expires 4/8/20). Please use NOT-AI-20-034 and NOT-GM-20-025 (listed above) |
4/8/20 |
NSF - National Science Foundation
- Rapid Response Research (RAPID) Funding Mechanism
- Requests for RAPID proposals may be for up to $200K and up to one year in duration. Well-justified proposals that exceed these limits may be entertained. All questions should be directed either to a program officer managing an NSF program with which the research would be aligned or to [email protected].
- NSF also encourages applying through existing funding opportunities.
PCORI
Complete list of funding opportunities
- COVID-19 Targeted PFA
- Due Date: May 26,2020 5pm ET
- Small studies: $2,500,000
- Large Studies: $5,000,000
- PCORI Funding Opportunity for COVID-19 Related Enhancements to Existing PCORI-Funded Research Projects
- On a rolling basis
- $500,000 limit (total costs)- higher amount on case-by-case basis
- PCORI Funding Opportunity for COVID-19 Related Enhancements to Existing PCORI-Funded Engagement Awards
- On a rolling basis
- $150,000 limit (total costs)
- PCORI Funding Opportunity for COVID-19 Related Enhancements to Existing PCORI-Funded Dissemination and Implementation Awards
- Rolling basis
- $500,000 limit (total costs)- higher amount on case-by-case basis
- Engagement Award Special Cycle: Supporting Engagement in and Dissemination of PCOR/CER in the Context of COVID-19
- Due Date: May 22, 2020 5pm ET
- $150,000 limit (total costs)
UC - RGPO University of California, Research Grants Program Office
- Emergency COVID-19 Research Seed Funding
- Applications accepted starting April 6th 2020 and continuously until availabe funds are expended
UCSF
- Program for Breakthrough Biomedical Research (PBBR) - Ultra-Rapid Funding for Projects Broadly Relevant to SARS CoV-2/COVID-19
- Due April 8th.
- As this in internal funding, PI can submit directly and do not need to work with their RSCs.
- Qualification for PBBR funding: at least one PI must be a member of BMS, PIBS or iPQB graduate training programs. However, non-affiliated faculty may serve as Co-PI’s on applications collaborative with an affiliated faculty. By this route, all faculty are welcome to apply.
- Please send requested materials as a single pdf file by email to Linda Reilly, PBBR Program Manager, [email protected]
- UCSF COVID-19 Rapid Response Pilot Grants
- Due April 21st
- As this in internal funding, PI can submit directly and do not need to work with their RSCs.
- Program contact: Gretchen Kiser, PhD, in the UCSF Research Development Office: 480.290.0207; [email protected]
US Army Medical Research & Development Commands's CDMRP
FY20 Peer Review Medical Research Program Funding Opportunities focused on COVID-19 and SARS-CoV-2 in two topic areas, "emerging viral diseases" and "respiratory health."
White House